博迅生物
(836504)
| 流通市值：1.95亿 | | | 总市值：6.78亿 |
| 流通股本：1248.51万 | | | 总股本：4333.31万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 23,522,483.19 | 142,272,377.62 | 102,592,617.84 | 67,154,847.21 |
| 营业收入 | 23,522,483.19 | 142,272,377.62 | 102,592,617.84 | 67,154,847.21 |
| 二、营业总成本 | 22,172,720.15 | 121,581,189.45 | 87,366,464.59 | 55,071,865.93 |
| 营业成本 | 13,173,961.25 | 83,935,216.18 | 59,877,426.84 | 38,947,270.21 |
| 税金及附加 | 200,684.05 | 1,229,316.84 | 764,161.06 | 459,405.7 |
| 销售费用 | 3,238,347.34 | 12,643,976.4 | 9,548,608.88 | 5,477,985.67 |
| 管理费用 | 4,141,557.74 | 16,581,860.02 | 12,337,095.87 | 7,271,538.15 |
| 研发费用 | 1,584,468 | 7,829,023.6 | 5,258,696.12 | 3,103,451.68 |
| 财务费用 | -166,298.23 | -638,203.59 | -419,524.18 | -187,785.48 |
| 其中:利息费用 | 99,588.99 | 753,761.49 | 49,156.04 | 35,284.39 |
| 其中:利息收入 | 268,918.35 | 1,414,122.31 | 486,335.51 | 238,784.23 |
| 加:公允价值变动收益 | 140,082.08 | - | - | - |
| 加:投资收益 | 334,134.69 | 672,370.82 | 361,667.28 | 245,296.82 |
| 资产处置收益 | - | -1,445.19 | - | - |
| 资产减值损失(新) | -396,491.93 | -1,118,874 | -725,662.78 | -648,499.48 |
| 信用减值损失(新) | -755,678.04 | 121,702.31 | -1,112,391.56 | -1,338,751.52 |
| 其他收益 | 815,347.07 | 5,913,893.39 | 3,863,452.95 | 2,553,617.7 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,487,156.91 | 26,278,835.5 | 17,613,219.14 | 12,894,644.8 |
| 加:营业外收入 | - | 3,500,000 | - | 13,946.9 |
| 减:营业外支出 | 10,107.38 | 36,309.72 | 25,651.05 | 20,000 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,477,049.53 | 29,742,525.78 | 17,587,568.09 | 12,888,591.7 |
| 减:所得税费用 | 314,351.66 | 3,071,128.73 | 2,254,170.33 | 1,835,270.47 |
| 六、净利润 | 1,162,697.87 | 26,671,397.05 | 15,333,397.76 | 11,053,321.23 |
| 持续经营净利润 | 1,162,697.87 | 26,671,397.05 | 15,333,397.76 | 11,053,321.23 |
| 归属于母公司股东的净利润 | 1,162,697.87 | 26,671,397.05 | 15,333,397.76 | 11,053,321.23 |
| (一)基本每股收益 | 0.03 | 0.72 | 0.43 | 0.32 |
| (二)稀释每股收益 | 0.03 | 0.72 | 0.43 | 0.32 |
| 九、综合收益总额 | 1,162,697.87 | 26,671,397.05 | 15,333,397.76 | 11,053,321.23 |
| 归属于母公司股东的综合收益总额 | 1,162,697.87 | 26,671,397.05 | 15,333,397.76 | 11,053,321.23 |
| 公告日期 | 2024-04-26 | 2024-03-15 | 2023-10-30 | 2023-07-31 |
| 审计意见(境内) | | 标准无保留意见 | | |